Generally, these tumors will be classified as GBM because the of release of circulating tumor cells is associated with EGFR gene amplification, indicating that hematogenous GBM spread out is an intrinsic feature of GBM biology [1, 2, 7, 65]. This evidence concerns the gene EGFR and glioblastoma.